Loading company…
Shanghai Beitongji Biotechnology makes animal cell culture media and process services for biopharma and cell therapy clients.
The company has developed nearly 100 types of serum-free media for cell lines, including the Eden series for CHO cells, and provides one-stop cell culture process development, medium design and manufacturing. It has supported more than 80 clinical projects and works with over 200 partners, including CSPC, BGI and Boan Biotech. Established in 2014 and based in Shanghai, China, it had 108 employees as of 2023 and raised more than CNY 200 million in Series C funding in May 2023 to expand research and infrastructure.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Shanghai Beitongji Biotechnology Co., Ltd.? This is my company